MINNEAPOLIS and BOSTON, May 4,
2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:
TECH) and 908 Devices (NASDAQ: MASS) today announced a joint
collaboration to develop an extended workflow solution for protein
characterization. Bio-Techne, a global life sciences company
providing innovative tools and bioactive reagents for the research
and clinical diagnostic communities, and owner of the leading
ProteinSimple branded protein analysis portfolio of products, will
pair its Maurice icIEF separation instrument with 908 Devices
ZipChip device to deliver a seamless workflow for deeper protein
characterization. Maurice and the iCE technology are the gold
standard in protein characterization, providing absorbance and
native fluorescence icIEF detection as well as CE-SDS, saving
significant development time and reducing the time to
commercialization.
908 Devices, a pioneer of purpose-built handheld and desktop
mass spec devices for chemical and biomolecular analysis, enables
high-resolution separation and mass spec sample introduction with
its plug-and-play open access platform ZipChip, which directly
integrates electrospray ionization with mass spectrometry. The
ZipChip integrates with Thermo
Fisher, Sciex, and Bruker mass spectrometers and leverages
Capillary Electrophoresis (CE) and electrospray ionization
technology in order to minimize sample prep burden, perform
high-resolution separations and directly introduce samples into a
mass spec instrument.
Maurice paired with 908 Devices ZipChip allows in-depth
characterization of biotherapeutics on an intact and near-native
level. This workflow solution will increase scientists' drug
development efficiency through additional rapid, high-resolution
separation techniques coupled with mass spectrometry
identification.
"We are very excited to collaborate with 908 Devices to provide
an integrated workflow that enables fraction analysis for our
Maurice users. Analyzing protein charge isoforms is a critical
requirement and this enhanced capability using Maurice with the
ZipChip and MS will provide a deeper understanding of a molecule
through the various stages of development," stated Dave Eansor, President of Bio-Techne's Protein
Sciences Segment. "Our iCE technology has been the gold standard in
protein charge characterization for more than 20 years and this
collaboration will provide additional value to the iCE
community."
"By partnering with Bio-Techne and leveraging their market
leading Maurice icIEF platform with our ZipChip device, we are
together extending the workflow for customers conducting detailed
protein characterization of charge variants," said Dr. Kevin J. Knopp, CEO and co-founder of 908
Devices. "This collaboration helps advance our reach into the
biopharmaceutical market."
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH)
is a global life sciences company providing innovative tools and
bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With thousands of
products in its portfolio, Bio-Techne generated approximately
$739 million in net sales in fiscal
2020 and has over 2,500 employees worldwide. For more information
on Bio-Techne and its brands, please visit www.bio-techne.com.
Investor Relations Contact:
David Clair, Senior Director,
Investor Relations and Corporate Development
david.clair@bio-techne.com
612-656-4416
About 908 Devices
908
Devices (NASDAQ:MASS) is democratizing laboratory mass
spectrometry with its simple handheld and desktop devices,
addressing critical-to-life applications. The Company's
devices are used at the point-of-need to interrogate unknown and
invisible materials and provide quick, actionable answers to
directly address some of the most critical problems in life
sciences research, bioprocessing, pharma / biopharma, forensics and
adjacent markets. The Company is headquartered in the heart of
Boston, where it designs and
manufactures innovative products that bring together the power of
mass spectrometry, microfluidic separations, software automation,
and machine learning.
908 Devices Contacts
Emily Fang
PAN Communications for 908 Devices
908devices@pancomm.com
Carrie Mendivil,
IR@908devices.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bio-techne-and-908-devices-announce-joint-collaboration-301281096.html
SOURCE Bio-Techne Corporation